University of Oklahoma Health Sciences at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of Oklahoma Health Sciences brings 2 presentations to AMP 2026 in Seattle. Its program covers functional and computational approaches to deciding whether a genetic variant is pathogenic, and molecular residual disease surveillance in breast cancer.
| Organization | AMP 2026 Attendance |
|---|---|
University of Oklahoma Health Sciences Oklahoma City, OK | |
Academic health centre in Oklahoma City with colleges of medicine and public health, a hospital system and a cancer centre. | Workshop Wed, Nov 11 8:00am–8:50am Molecular Residual Disease in Breast Cancer: Advancing Surveillance and Clinical Decision-Making Tissue-informed circulating tumor DNA testing in breast cancer, from baseline through surveillance and early recurrence detection. Session Fri, Nov 13 10:15am–11:45am Resolving the Unknown: Functional and Computational Approaches to Determine Pathogenicity of Genetic Variants
|
Instantly find 20 buyers from University of Oklahoma Health Sciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction